448 related articles for article (PubMed ID: 26162437)
1. Epigenetics and systemic sclerosis.
Altorok N; Kahaleh B
Semin Immunopathol; 2015 Sep; 37(5):453-62. PubMed ID: 26162437
[TBL] [Abstract][Full Text] [Related]
2. Epigenetics and pathogenesis of systemic sclerosis; the ins and outs.
Aslani S; Sobhani S; Gharibdoost F; Jamshidi A; Mahmoudi M
Hum Immunol; 2018 Mar; 79(3):178-187. PubMed ID: 29330110
[TBL] [Abstract][Full Text] [Related]
3. Genetic and epigenetic abnormalities in systemic sclerosis.
Makino T; Jinnin M
J Dermatol; 2016 Jan; 43(1):10-8. PubMed ID: 26782002
[TBL] [Abstract][Full Text] [Related]
4. Epigenetic mechanisms: An emerging role in pathogenesis and its therapeutic potential in systemic sclerosis.
Luo Y; Wang Y; Shu Y; Lu Q; Xiao R
Int J Biochem Cell Biol; 2015 Oct; 67():92-100. PubMed ID: 26043891
[TBL] [Abstract][Full Text] [Related]
5. The role of genetics and epigenetics in the pathogenesis of systemic sclerosis.
Broen JC; Radstake TR; Rossato M
Nat Rev Rheumatol; 2014 Nov; 10(11):671-81. PubMed ID: 25136786
[TBL] [Abstract][Full Text] [Related]
6. Epigenetics, the holy grail in the pathogenesis of systemic sclerosis.
Altorok N; Almeshal N; Wang Y; Kahaleh B
Rheumatology (Oxford); 2015 Oct; 54(10):1759-70. PubMed ID: 24740406
[TBL] [Abstract][Full Text] [Related]
7. Unfolding the pathogenesis of scleroderma through genomics and epigenomics.
Tsou PS; Sawalha AH
J Autoimmun; 2017 Sep; 83():73-94. PubMed ID: 28526340
[TBL] [Abstract][Full Text] [Related]
8. New insights into the genetics and epigenetics of systemic sclerosis.
Angiolilli C; Marut W; van der Kroef M; Chouri E; Reedquist KA; Radstake TRDJ
Nat Rev Rheumatol; 2018 Nov; 14(11):657-673. PubMed ID: 30305700
[TBL] [Abstract][Full Text] [Related]
9. Critical roles of microRNAs in the pathogenesis of systemic sclerosis: New advances, challenges and potential directions.
Miao CG; Xiong YY; Yu H; Zhang XL; Qin MS; Song TW; Du CL
Int Immunopharmacol; 2015 Sep; 28(1):626-33. PubMed ID: 26241784
[TBL] [Abstract][Full Text] [Related]
10. Association between enhanced type I collagen expression and epigenetic repression of the FLI1 gene in scleroderma fibroblasts.
Wang Y; Fan PS; Kahaleh B
Arthritis Rheum; 2006 Jul; 54(7):2271-9. PubMed ID: 16802366
[TBL] [Abstract][Full Text] [Related]
11. Epigenetics: The Future Direction in Systemic Sclerosis.
Walczyk M; Paradowska-Gorycka A; Olesinska M
Scand J Immunol; 2017 Dec; 86(6):427-435. PubMed ID: 28930377
[TBL] [Abstract][Full Text] [Related]
12. Systemic sclerosis: genetics and epigenetics.
Luo Y; Wang Y; Wang Q; Xiao R; Lu Q
J Autoimmun; 2013 Mar; 41():161-7. PubMed ID: 23415078
[TBL] [Abstract][Full Text] [Related]
13. The Epigenetic Regulation of Scleroderma and Its Clinical Application.
Luo Y; Xiao R
Adv Exp Med Biol; 2020; 1253():375-403. PubMed ID: 32445102
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic factors as drivers of fibrosis in systemic sclerosis.
Bergmann C; Distler JH
Epigenomics; 2017 Apr; 9(4):463-477. PubMed ID: 28343418
[TBL] [Abstract][Full Text] [Related]
15. [Systemic sclerosis. Part 2. Epigenetic factors in the pathogenesis of clinical manifestations].
Fryc J; Midro AT; Panasiuk B; Sierakowski S
Przegl Lek; 2015; 72(1):25-30. PubMed ID: 26076574
[TBL] [Abstract][Full Text] [Related]
16. Histone modifications underlie monocyte dysregulation in patients with systemic sclerosis, underlining the treatment potential of epigenetic targeting.
van der Kroef M; Castellucci M; Mokry M; Cossu M; Garonzi M; Bossini-Castillo LM; Chouri E; Wichers CGK; Beretta L; Trombetta E; Silva-Cardoso S; Vazirpanah N; Carvalheiro T; Angiolilli C; Bekker CPJ; Affandi AJ; Reedquist KA; Bonte-Mineur F; Zirkzee EJM; Bazzoni F; Radstake TRDJ; Rossato M
Ann Rheum Dis; 2019 Apr; 78(4):529-538. PubMed ID: 30793699
[TBL] [Abstract][Full Text] [Related]
17. Integrative analysis of DNA methylation in discordant twins unveils distinct architectures of systemic sclerosis subsets.
Ramos PS; Zimmerman KD; Haddad S; Langefeld CD; Medsger TA; Feghali-Bostwick CA
Clin Epigenetics; 2019 Apr; 11(1):58. PubMed ID: 30947741
[TBL] [Abstract][Full Text] [Related]
18. Gene Profiling in Patients with Systemic Sclerosis Reveals the Presence of Oncogenic Gene Signatures.
Dolcino M; Pelosi A; Fiore PF; Patuzzo G; Tinazzi E; Lunardi C; Puccetti A
Front Immunol; 2018; 9():449. PubMed ID: 29559981
[TBL] [Abstract][Full Text] [Related]
19. Epigenetic modulation as a therapy in systemic sclerosis.
O'Reilly S
Rheumatology (Oxford); 2019 Feb; 58(2):191-196. PubMed ID: 29579252
[TBL] [Abstract][Full Text] [Related]
20. Critical Link Between Epigenetics and Transcription Factors in the Induction of Autoimmunity: a Comprehensive Review.
Wu H; Zhao M; Yoshimura A; Chang C; Lu Q
Clin Rev Allergy Immunol; 2016 Jun; 50(3):333-44. PubMed ID: 26969025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
